A critical advance in cancer study is occurring with the use of VHH fragments to re-engage dysfunctional p53. This crucial malignant inhibitor protein is frequently disabled in various types of malignancies, causing https://sitesrow.com/story12013065/vhh-fragments-reactivate-p53-the-promising-pathway-for-cancer-management